Literature DB >> 3702419

Metabolism of [3H]oestradiol in vivo by normal breast and tumour tissue in postmenopausal women.

R C Bonney, M J Reed, P A Beranek, M W Ghilchik, V H James.   

Abstract

Tumour and normal breast tissue was obtained from postmenopausal breast cancer patients following [3H]oestradiol infusion (50 mu Ci over a 12 h period). The fraction of radioactivity present as oestradiol or oestrone was measured and the results expressed both as the ratio of oestradiol-oestrone and as the percentage oestrogen present as oestrone, and the findings compared with in vitro measurements of 17 beta-hydroxysteroid dehydrogenase activity. Concentrations of 5-androstene-3 beta, 17 beta-diol, dehydroepiandrosterone and its sulphate and testosterone were measured and related to oestradiol metabolism. The study demonstrated that tumour tissue is less able to metabolise oestradiol to oestrone than is normal breast tissue and indicated that the ability of the tissue to detoxify oestradiol may be dependent on cofactor availability. The results also supported the possibility that increased tissue concentrations of adrenal androgens inhibit oestradiol and thus increase tissue exposure to oestradiol.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3702419     DOI: 10.1016/0022-4731(86)90082-8

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  4 in total

Review 1.  Estrogen metabolism as a regulator of estrogen action in the mammary gland.

Authors:  M Miettinen; V Isomaa; H Peltoketo; D Ghosh; P Vihko
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-07       Impact factor: 2.673

2.  Human oestrogenic 17beta-hydroxysteroid dehydrogenase specificity: enzyme regulation through an NADPH-dependent substrate inhibition towards the highly specific oestrone reduction.

Authors:  A Gangloff; A Garneau; Y W Huang; F Yang; S X Lin
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

3.  Site-directed mutagenesis of the putative active site of human 17 beta-hydroxysteroid dehydrogenase type 1.

Authors:  T J Puranen; M H Poutanen; H E Peltoketo; P T Vihko; R K Vihko
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

4.  The gene for 17 beta-hydroxysteroid dehydrogenase maps to human chromosome 17, bands q12-q21, and shows an RFLP with ScaI.

Authors:  R Winqvist; H Peltoketo; V Isomaa; K H Grzeschik; A Mannermaa; R Vihko
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.